Received Aug 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3S54K | — |
adult dose given to a pediatric patient; adult dose given to a pediatric patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult product administered to child in a 6-year-old female patient who received HAV (Havrix) (batch number 3S54K, expiry date 18-DEC-2025) for prophylaxis. On 23-JUL-2025, the patient received Havrix. On 23-JUL-2025, an unknown time after receiving Havrix, the patient experienced adult product administered to child (Verbatim: adult dose given to a pediatric patient) and accidental overdose (Verbatim: adult dose given to a pediatric patient). The outcome of the adult product administered to child and accidental overdose were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 24-JUL-2025 The medical assistant called asking for advice because an adult dose of Havrix was administered by mistake to a six-year-old pediatric patient which led to, adult product administered to child and accidental overdose. The Vaccine Administration Facility was the same as Primary Reporter.